Orecchia, Roberto

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology

Chemotherapy-induced cardiotoxicity and mitigationCardiac tumors and thrombi

Cited by 1,031

Radiotherapy-related fatigue

Jereczek-Fossa, B. A., Marsiglia, H. R., & Orecchia, R. (2002) · Critical Reviews in Oncology/Hematology

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 240

Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning.

Cremonesi, M., Ferrari, M. E., Bodei, L., Chiesa, C., Sarnelli, A., Garibaldi, C., Pacilio, M., Strigari, L., Summers, P. E., Orecchia, R., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging

Radiopharmaceutical Chemistry and ApplicationsNeuroendocrine Tumor Research Advances

Cited by 141

Fatigue During Head-And-Neck Radiotherapy: Prospective Study on 117 Consecutive Patients

Jereczek-Fossa, B. A., Santoro, L., Alterio, D., Franchi, B., Fiore, M. R., Fossati, P., Kowalczyk, A., Canino, P., Ansarin, M., & Orecchia, R. (2007) · International Journal of Radiation Oncology*Biology*Physics

Head and Neck Cancer StudiesCancer survivorship and care

Cited by 77

Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells

Biagiotti, G., Cazzoli, R., Andreozzi, P., Aresta, G., Francesco, M., Mangini, C., di Gianvincenzo, P., Tobia, C., Recchia, S., Polito, L., et al. (2024) · Nanoscale Horizons

Radiation Therapy and DosimetryNanoplatforms for cancer theranostics

Cited by 11